Costco offers major discounts on Ozempic and Wegovy for uninsured customers
Novo Nordisk’s Ozempic and Wegovy Now Available at Costco Pharmacies Nationwide
In an effort to make Ozempic and Wegovy more accessible, Novo Nordisk has announced the availability of these popular weight loss injectable pens at Costco pharmacies across the United States. Starting this Friday, Costco members with a valid prescription can purchase a four-week supply for $499.
Strategic Partnership with Costco Expands Accessibility
This move comes as Novo Nordisk aims to combat competition from compounding pharmacies and medical spas offering cheaper alternatives to their branded medications. David Moore, president of Novo Nordisk U.S., emphasized the importance of partnering with Costco, stating, “We want to make sure we offer the real, authentic Wegovy and Ozempic where patients seek care. We know that Costco is a trusted brand.” This collaboration marks a significant step in enhancing customer access to these medications through a reliable and widespread retailer.
Cost and Insurance Considerations for Costco Members
Costco members who are executive members or hold a Costco Citibank credit card can benefit from cash back rewards under the chain’s prescription program. For those with insurance coverage, the cost of Ozempic and Wegovy will vary based on individual plans, while the out-of-pocket cost remains $499 for members without insurance coverage. The discounted prescriptions will be made available at over 600 Costco pharmacies nationwide.
Potential Health Benefits of Ozempic and Wegovy
Significant research has highlighted the potential health benefits of these medications in reducing stroke risk, treating liver disease, and promoting cardiovascular health. Dr. Rekha Kumar from Weill Cornell Medicine considers these drugs a breakthrough in diabetes treatment, although they largely remain out of reach for uninsured individuals.
The Challenge of Broader Accessibility
- Despite the availability of a self-pay option, around one in five people with private insurance do not have coverage for brand-name GLP-1 medications, according to GoodRX.
- In 2024, only 13 states will cover GLP-1 drugs for obesity, revealing a gap in insurance coverage.
- Novo Nordisk notes that for those with coverage, medication costs average $25 per month.
Narrowing the Accessibility Gap: Expert Insights
Dr. Harlan Krumholz of Yale School of Medicine emphasized the need for broader access to these medicines, especially for lower-income individuals without adequate insurance. “If we really want to make the biggest difference in the nation’s health, we have to ensure that those who would benefit most have access to these beneficial medications,” he asserted, highlighting the ongoing challenge of achieving equitable healthcare distribution.
